Aligos therapeutics to announce first quarter 2022 results may 4, 2022

South san francisco, calif., april 27, 2022 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that it will report the company's first quarter 2022 financial results on wednesday, may 4, 2022 after the close of u.s. financial markets.
ALGS Ratings Summary
Quant
ALGS Quant Ranking
Sector
Industry
Quant Rating
Quant Score